Saluda Medical closed a $100 million finance round, the spine company said Jan. 10.
Financing was led by Redmile Group and other existing investors, according to a news release. The money will support commercialization of the Evoke closed-loop spinal cord stimulator.
Saluda's Evoke system is the first designed to sense and measure neural responses and automatically adjust therapy.